Skip to main content
SpringerLink
Log in

Managing Hypertension with Ambulatory Blood Pressure Monitoring

  • Hypertension (WB White and AJ Peixoto, Section Editors)
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

Abstract

There has been a dramatic shift in the manner in which blood pressure (BP) is measured to provide far more comprehensive clinical information than that provided by a single set of office BP readings. Extensive clinical and epidemiological research shows an important role of ambulatory BP monitoring (ABPM) in the management of hypertensive patients. A 24-h BP profile helps to determine the absence of nocturnal dipping status and evaluate BP control in patients on antihypertensive therapy. The ability to detect white-coat or masked hypertension is enhanced by ambulatory BP monitoring. In 2001, the Center for Medicare and Medicaid Services approved ABPM for reimbursement for the identification of patients with white-coat hypertension. In 2011, the National Institute for Health and Clinical Excellence (NICE) in the UK published guidelines that recommended the routine use of ABPM in all patients suspected of having hypertension. The European Society of Hypertension (ESH) 2013 guidelines also support greater use of ABPM in clinical practice. While the advantages of ABPM are apparent from a clinical perspective, its use should be considered in relation to its cost, the complexity of data evaluation, as well as patient inconvenience. In this review, we evaluate the clinical importance of ABPM, highlighting its role in the current management of hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Pickering TG, White WB. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens. 2010;4:56–61. Consensus document on clinical and practical recommendations for using home and ambulatory blood pressure monitoring.

    Article  PubMed  Google Scholar 

  2. Mancia G, Fagard R, Narkiewicz K, Task Force Members, et al. 2013 ESH/ ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357. Consensus guidelines document of the ESH/ESC on management of hypertension.

    Article  CAS  PubMed  Google Scholar 

  3. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9:1–11.

    Article  CAS  PubMed  Google Scholar 

  4. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716.

    Article  PubMed  Google Scholar 

  5. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139–85.

    Article  CAS  PubMed  Google Scholar 

  6. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999, 17:151–183.

  7. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.

    Article  CAS  PubMed  Google Scholar 

  8. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–15.

    Article  PubMed  Google Scholar 

  9. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156–61.

    Article  CAS  PubMed  Google Scholar 

  10. CMS.gov. Centers for Medicare & Medicaid Services. Medicare coverage policy decisions. ABPM monitoring (#CAG-00067N). 2001. http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=5&NcaName=Ambulatory+Blood+Pressure+Monitoring&ver=9&from=%252527lmrpstate%252527&contractor=22&name=CIGNA+Government+Services+(05535)+-+Carrier&letter_range=4&bc=gCAAAAAAIAAA. Assessed July 1 2014.

  11. National Institute for Health and Clinical Excellence (NICE). Hypertension: the clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. www.nice.org.uk/guidance/CG127. Assessed July 1 2014.

  12. O’Brien E, Parati G, Stergiou G, The European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–67. Consensus document on fundamentals and recommendations for ABPM.

    PubMed  Google Scholar 

  13. O’Brien E, Parati G, Stergiou G, et al. Ambulatory blood pressure measurement: what is the international consensus? Hypertension. 2013;62:988–94. Summary of the consensus document of ESH emphasizing clinically relevant issues in the use of ABPM.

    Article  PubMed  Google Scholar 

  14. Bloch MJ, Basile JN. New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011;13:785–6.

    Article  Google Scholar 

  15. Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. An important summary of the updated NICE guidelines on the management of hypertension and one of the first evidence to support using ambulatory blood pressure monitoring in clinical practice.

    Article  PubMed  Google Scholar 

  16. White WB. Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med. 2003;348:2377–8.

    Article  PubMed  Google Scholar 

  17. White WB. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit. 1997;2:47–51.

    PubMed  Google Scholar 

  18. Hermida RC, Smolensky MH, Ayala DE, et al. 2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30:3,355–410.

    Google Scholar 

  19. Sundberg S, Kohvakka A, Gordin A. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens. 1988;6:393–6.

    Article  CAS  PubMed  Google Scholar 

  20. Sternberg H, Rosenthal T, Shamiss A, Green M. Altered circadian rhythm of blood pressure in shift workers. J Hum Hypertens. 1995;9:349–53.

    CAS  PubMed  Google Scholar 

  21. White WB, Mansoor GA, Tendler BE, Anwar YA. Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy. Blood Press Monit. 1998;3:43–51.

    PubMed  Google Scholar 

  22. Di Iorio A, Marini E, Lupinetti M, Zito M, Abate G. Blood pressure rhythm and prevalence of vascular events in hypertensive subjects. Age Ageing. 1999;28:23–8.

    Article  PubMed  Google Scholar 

  23. Sherwood A, Thurston R, Steffen P, et al. Blunted nighttime blood pressure dipping in postmenopausal women. Am J Hypertens. 2001;14:749–54.

    Article  CAS  PubMed  Google Scholar 

  24. Harshfield GA, Hwang C, Grim CE. Circadian variation of blood pressure in blacks: influence of age, gender and activity. J Hum Hypertens. 1990;4:43–7.

    CAS  PubMed  Google Scholar 

  25. Cuspidi C, Giudici V, Negri F, Sala C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review. Expert Rev Cardiovasc Ther. 2010;8:781–92.

    Article  PubMed  Google Scholar 

  26. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.

    Article  CAS  PubMed  Google Scholar 

  27. Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036–45.

    Article  CAS  PubMed  Google Scholar 

  28. Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.

    Article  PubMed  Google Scholar 

  29. Brotman DJ, Davidson MB, Boumitri M, et al. Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 2008;21:92–7.

    Article  PubMed  Google Scholar 

  30. Hermida RC, Ayala DE, Fernandez JR, et al. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30:68–86.

    Article  PubMed  Google Scholar 

  31. White WB, Larocca GM. Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the “dipping” proportion. Am J Cardiol. 2003;92:1439–41.

    Article  PubMed  Google Scholar 

  32. Mochizuki Y, Okutani M, Donfeng Y, et al. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens. 1998;11:403–9.

    Article  CAS  PubMed  Google Scholar 

  33. Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens. 1998;16:733–8.

    Article  CAS  PubMed  Google Scholar 

  34. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Hypertension. 2002;20:2183–9.

    Article  CAS  Google Scholar 

  35. Gorostidi M, Sobrino J, Segura J, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977–84.

    Article  CAS  PubMed  Google Scholar 

  36. de la Sierra A, Segura J, Gorostidi M, et al. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res. 2010;33:767–71.

    Article  PubMed  Google Scholar 

  37. de la Sierra A, Redon J, Banegas JR, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53:466–72.

    Article  PubMed  Google Scholar 

  38. Cuspidi C, Macca G, Sampieri L, et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens. 2001;19:1539–45.

    Article  CAS  PubMed  Google Scholar 

  39. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35:844–51.

    Article  CAS  PubMed  Google Scholar 

  40. Kario K, White WB. Early morning hypertension: what does it contribute to overall cardiovascular risk assessment? J Am Soc Hypertens. 2008;2:397–402.

    Article  PubMed  Google Scholar 

  41. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001;6:63–72.

    Article  CAS  PubMed  Google Scholar 

  42. Wroe SJ, Sandercock P, Bamford J, et al. Diurnal variation in incidence of stroke: Oxfordshire community stroke project. BMJ. 1992;304:155–7.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29:992–6.

    Article  CAS  PubMed  Google Scholar 

  44. Casetta I, Granieri E, Portaluppi F, Manfredini R. Circadian variability in hemorrhagic stroke. JAMA. 2002;287:1266–7.

    Article  PubMed  Google Scholar 

  45. Gallerani M, Manfredini R, Ricci L, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand. 1993;87:482–7.

    Article  CAS  PubMed  Google Scholar 

  46. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.

    Article  PubMed  Google Scholar 

  47. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006;47:149–54.

    Article  CAS  PubMed  Google Scholar 

  48. Li Y, Thijs L, Hansen TW, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040–8.

    Article  CAS  PubMed  Google Scholar 

  49. White WB. Importance of blood pressure control over a 24-hour period. J Manag Care Pharm. 2007;13(Suppl B):34–9.

    PubMed  Google Scholar 

  50. Hermida RC, Ayala DE, Mojon A, et al. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34:1270–6.

    Article  PubMed Central  PubMed  Google Scholar 

  51. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens. 1991;4:844–9.

    Article  CAS  PubMed  Google Scholar 

  52. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–8.

    Article  CAS  PubMed  Google Scholar 

  53. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24:52–8.

    Article  PubMed  Google Scholar 

  54. Mancia G, Bombelli M, Facchetti R, et al. Long term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54:226–32.

    Article  CAS  PubMed  Google Scholar 

  55. Franklin SS, Thijs L, Hansen TW, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564–71.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Bjorklund K, Lind L, Vessby B, et al. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation. 2002;106:63–8.

    Article  PubMed  Google Scholar 

  57. Sander GE, Giles TD. Resistant hypertension: concepts and approach to management. Curr Hypertens Rep. 2011;13:347–55.

    Article  PubMed  Google Scholar 

  58. O’Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring; recommendations of the British Hypertension Society. BMJ. 2000;320:1128–34.

    Article  PubMed Central  PubMed  Google Scholar 

  59. Yano Y, Bakris GL. Recognition and management of masked hypertension: a review and novel approach. J Am Soc Hypertens. 2013;7:244–52.

    Article  PubMed  Google Scholar 

  60. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18:772–8.

    Article  PubMed  Google Scholar 

  61. Pickering T, Davidson K, Gerin W, et al. Masked hypertension. Hypertension. 2002;40:795–6.

    Article  CAS  PubMed  Google Scholar 

  62. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564–72.

    Article  CAS  PubMed  Google Scholar 

  63. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R. Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens. 2010;23:1190–7. Illustrates that home blood pressure monitoring may not be adequate to detect masked hypertension.

    Article  PubMed  Google Scholar 

  64. Verberk WJ, Kessels AG, de Leeuw PW. Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens. 2008;21:969–75.

    Article  PubMed  Google Scholar 

  65. Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  66. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792–8.

    Article  CAS  PubMed  Google Scholar 

  67. Fagard RH, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102:1139–44.

    Article  CAS  PubMed  Google Scholar 

  68. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539–46.

    Article  CAS  PubMed  Google Scholar 

  69. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–53.

    Article  CAS  PubMed  Google Scholar 

  70. Minutolo R, Agarwal R, Borrelli S, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090–8. Demonstrates the importance and utility of using ambulatory blood pressure monitoring in patients with chronic kidney disease as it relates to cardiovascular and renal outcomes.

    Article  PubMed  Google Scholar 

  71. Neutel JM. The importance of 24-h blood pressure control. Blood Press Monit. 2001;6:9–16.

    Article  CAS  PubMed  Google Scholar 

  72. White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens. 2004;17:347–53.

    Article  CAS  PubMed  Google Scholar 

  73. O’Brien E. The value of 24-h blood pressure monitoring to assess the efficacy of antihypertensive drug treatment. Hot Topics Hypertens. 2011;4:7–23.

    Google Scholar 

  74. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27:1629–51. This article provides information on the effect of timing of hypertension treatment using ambulatory blood pressure monitoring and actigraphy.

    Article  PubMed  Google Scholar 

  75. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004;22:435–45.

    Article  CAS  PubMed  Google Scholar 

  76. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823–7.

    Article  CAS  PubMed  Google Scholar 

  77. Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J Am Soc Hypertens. 2008;2:192–202.

    Article  PubMed  Google Scholar 

  78. Mule G, Caimi G, Cottone S, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9:123–9.

    Article  PubMed  Google Scholar 

  79. Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res. 2004;27:633–9.

    Article  PubMed  Google Scholar 

  80. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.

    Article  CAS  PubMed  Google Scholar 

  81. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.

    Article  PubMed  Google Scholar 

  82. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406–11.

    Article  CAS  PubMed  Google Scholar 

  83. White WB, Maraka S. Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring? Curr Hypertens Rep. 2012;14:366–73.

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

William B. White and Vinay Gulati declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

  1. Division of Hypertension and Clinical Pharmacology, Calhoun Cardiology Center, University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT, 06032-3940, USA

    William B. White

  2. Department of Cardiology, University of Connecticut School of Medicine and Hartford Hospital, 263 Farmington Avenue, Farmington, CT, 06032-3940, USA

    Vinay Gulati

Authors
  1. William B. White
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Vinay Gulati
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William B. White.

Additional information

This article is part of the Topical Collection on Hypertension

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

White, W.B., Gulati, V. Managing Hypertension with Ambulatory Blood Pressure Monitoring. Curr Cardiol Rep 17, 2 (2015). https://doi.org/10.1007/s11886-014-0556-6

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11886-014-0556-6

Keywords

Search

Navigation